CT screening examinations

Comment

Ferris M Hall. AJR Am J Roentgenol. 2003 Apr.

. 2003 Apr;180(4):1178-9; author reply 1179.

doi: 10.2214/ajr.180.4.1801178b.

No abstract available

Comment on

Whole-body CT screening: edging toward commerce.
Rogers LF. Rogers LF. AJR Am J Roentgenol. 2002 Oct;179(4):823. doi: 10.2214/ajr.179.4.1790823. AJR Am J Roentgenol. 2002. PMID: 12239017 No abstract available.
Screening for preclinical disease: test and disease characteristics.
Herman CR, Gill HK, Eng J, Fajardo LL. Herman CR, et al. AJR Am J Roentgenol. 2002 Oct;179(4):825-31. doi: 10.2214/ajr.179.4.1790825. AJR Am J Roentgenol. 2002. PMID: 12239019 No abstract available.
CT screening for lung cancer.
Swensen SJ. Swensen SJ. AJR Am J Roentgenol. 2002 Oct;179(4):833-6. doi: 10.2214/ajr.179.4.1790833. AJR Am J Roentgenol. 2002. PMID: 12239020 No abstract available.
Liability of performing CT screening for coronary artery disease and lung cancer.
Berlin L. Berlin L. AJR Am J Roentgenol. 2002 Oct;179(4):837-42. doi: 10.2214/ajr.179.4.1790837. AJR Am J Roentgenol. 2002. PMID: 12239021 No abstract available.